Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
| Line 66: | Line 66: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] | |||
Revision as of 02:59, 27 November 2017
| Neuroendocrine tumors | |
| ICD-9 | 209 |
|---|---|
| ICD-O: | M8013/3, M8041/3, M8246/3, M8247/3, M8574/3 |
| MedlinePlus | 000393 |
| MeSH | D018358 |
|
Neuroendocrine tumors Microchapters |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neuroendocrine tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | PET | Endoscopy | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
External links
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.